-
A Reply to Liu
Yifan Han,
Xiaoyuan Xu
American Journal of Hematology
· Гематология
· 2026-11-03
-
Prognostic Impact of FLT3‐ITD Microclones in AML: An EHA AML‐Specialized Working Group Study
Carmelo Gurnari,
Tiziana Ottone,
Alfonso Piciocchi,
Daniela Späth,
Annika Meid,
Giovanni Marsili,
Emiliano Fabiani,
Francesca Romano,
Maria Rosaria Pascale,
Paola Ricci,
Patrizia Chiusolo,
Mauro Di Ianni,
Marta Sobas,
Lorenzo Brunetti,
Guadalupe Oñate,
Joana Brioso Infante,
Jacopo Nanni,
Calogero Vetro,
Matilde Boada,
Anna Candoni,
Jorge Sierra,
Nicola Potter,
Amanda Gilkes,
Sean James Johnson,
Ian Thomas,
Brian Huntly,
Adriano Venditti,
Nigel Russell,
Richard Dillon,
American Journal of Hematology
· Гематология
· 2026-11-02
ABSTRACT The 2022 ELN recommendations reclassified fms‐like tyrosine kinase‐3 ( FLT3 )‐ITD mutated acute myeloid leukemia (AML) as intermediate‐risk, irrespective of allelic ratio (AR), and designated capillary electrophoresis (CE) as...
-
Efficacy and Safety of NTQ5082 in Complement Inhibitor‐Naïve Patients With Paroxysmal Nocturnal Hemoglobinuria
Li Zhang,
Gaixiang Xu,
Linghui Xia,
Lin Liu,
Yumeng Zhou,
Rongfeng Zhou,
Shujun Chen,
Fengkui Zhang,
Hongyan Tong
American Journal of Hematology
· Гематология
· 2026-10-30
ABSTRACT Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematologic disorder characterized by complement‐mediated intravascular hemolysis, pancytopenia, and thrombosis. NTQ5082 is a novel oral selective complement factor B (CFB)...
-
Rapidly Progressive Multi‐Organ Failure and Fat Embolism Syndrome in Sickle Cell Disease: Red Cell Transfusion Followed by Therapeutic Plasma Exchange
Jessica L. Moore,
Cassandra Chua,
Amy Sobota,
Caitlin Neri,
Charlene Sylvestre,
Britney Bell,
Robyn T. Cohen,
Elizabeth S. Klings
American Journal of Hematology
· Гематология
· 2026-10-30
-
Clinical Experience of Iptacopan in Paroxysmal Nocturnal Hemoglobinuria
Matthew Holt,
Richard J. Kelly,
Regis Peffault de Latour,
Morag Griffin,
Shreyans Gandhi,
Edouard Forcade,
Francesco Versino,
Roochi Trikha,
Alexandra Pike,
Joanna Large,
Michael Loschi,
Marc Michel,
Petra Muus,
Talha Munir,
Alice Garnier,
Simona Pagliuca,
Yosr Hicheri,
Isabelle Brindel,
Sateesh Nagumantry,
Lynda Maafa,
Louise M. Arnold,
Austin Kulasekararaj,
Flore Sicre de Fontbrune
American Journal of Hematology
· Гематология
· 2026-10-28
ABSTRACT Iptacopan, an oral Factor B inhibitor, is approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). In clinical trials it was safe and effective but real‐world data, particularly in patients with associated bone...
-
Integrated Multi‐Omic Characterization of Hexokinase‐1 Deficiency in Red Blood Cells Reveals Altered Redox Homeostasis, Membrane Remodeling, and Features of Incomplete Erythroid Maturation
Zachary B. Haiman,
Alkmini T. Anastasiadi,
Polyxeni Delaporta,
Daniel Stephenson,
Monika Dzieciatkowska,
Travis Nemkov,
Grier P. Page,
Vasiliki Chouliara,
Stavros Glentis,
Anne‐Sophie Adam,
Gregory R. Keele,
Xutao Deng,
Michael P. Busch,
Philip J. Norris,
Antonis Kattamis,
Vassilis L. Tzounakas,
Angelo D'Alessandro
American Journal of Hematology
· Гематология
· 2026-10-27
ABSTRACT Hexokinase 1 (HK1) deficiency is a rare cause of hereditary nonspherocytic hemolytic anemia characterized by impaired erythrocyte glycolysis, but its broader molecular consequences of HK1 dysfunction remain poorly understood....
-
Prognostic Impact of FLT3‐ITD Allelic Ratio in AML Patients Treated With High‐Dose Anthracycline and a FLT3 Inhibitor
Mathieu Leclerc,
Etienne Audureau,
Nicolas Duployez,
Mathilde Hunault,
Emmanuelle Tavernier,
Cécile Pautas,
Sarah Bertoli,
Emmanuel Raffoux,
Marie‐Anne Hospital,
Tony Marchand,
Maël Heiblig,
Sylvain Chantepie,
Martin Carre,
Pierre Peterlin,
Maria‐Pilar Gallego‐Hernanz,
Romain Guieze,
Célestine Simand,
Pascal Turlure,
Anne Huynh,
Emilie Lemasle,
Ludovic Gabellier,
Juliette Lambert,
Felipe Suarez,
Samy Chraibi,
Laurence Sanhes,
Karine Celli‐Lebras,
Ariane Mineur,
Claude
American Journal of Hematology
· Гематология
· 2026-10-27
ABSTRACT The prognostic value of FLT3 internal tandem duplication ( FLT3 ‐ITD) in acute myeloid leukemia (AML) has traditionally been stratified according to the ITD/wild‐type allelic ratio (AR) and NPM1 co‐mutation status. We evaluated...
-
Circulating Biomarkers Associated With Hereditary Hemorrhagic Telangiectasia Sensitive to ALK1 Modulation
Hanny Al‐Samkari,
Erin Murphy,
Huan Yue,
Cassi Friday,
Eric Duhaime,
John Lee,
Andy Sullivan,
Patrick Andre
American Journal of Hematology
· Гематология
· 2026-10-26
This article published in Early View in error. The article is under embargo and will republish on 15th December 2026.
-
Increased Risk of Subsequent Cancers in Patients With Sézary Syndrome
Julia Nenonen,
Despoina Tsakona,
Philip Curman,
Hanna Brauner
American Journal of Hematology
· Гематология
· 2026-10-26
-
New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification
Naseema Gangat,
Paola Guglielmelli,
Alessandro M. Vannucchi,
Ayalew Tefferi
American Journal of Hematology
· Гематология
· 2026-10-24
ABSTRACT Janus kinase inhibitors are the cornerstone of treatment for myelofibrosis, but have limited disease‐modifying activity. Combinations of ruxolitinib with pelabresib, navitoclax, or selinexor improve spleen responses, although...
-
Heritability of Transcranial Doppler Velocity in Sickle Cell Anemia Across Two Independent Pediatric Cohorts
Guolian Kang,
Clifford M. Takemoto,
Mitchell J. Weiss,
Parul Rai,
Deepa Manwani,
Sara R. Rashkin,
Chengzhou Wu,
Michael R. DeBaun
American Journal of Hematology
· Гематология
· 2026-10-23
-
Longevity in Thalassemia: Which Clock Are We Trying to Slow?
Khaled M. Musallam,
Shahrukh Hashmi,
Mohamed Al Ameri,
Ayman W. El‐Hattab,
Ali T. Taher
American Journal of Hematology
· Гематология
· 2026-10-22
-
Outcomes of Patients With AL Amyloidosis and End‐Stage Renal Disease After Initiation of Therapy
Foteini Theodorakakou,
Lilli Sophie Sester,
Ute Hegenbart,
Paolo Milani,
Claudia Bellofiore,
Erasmia Psimenou,
Charikleia Gakiopoulou,
Meletios A. Dimopoulos,
Giovanni Palladini,
Stefan O. Schönland,
Efstathios Kastritis
American Journal of Hematology
· Гематология
· 2026-10-21
ABSTRACT In AL amyloidosis, advanced renal disease can impact treatment options and cause significant morbidity. Patients with ESRD requiring dialysis are a group with currently unmet needs. In this collaborative study, we identified...
-
Voxelotor in Children With Conditional Cerebral Blood Flow Velocity: What HOPE Kids 2 Teaches Us About Efficacy, Mortality, and Malaria Risk in Africa
Jeffrey G. Edwards,
Julie Makani,
Natasha M. Archer
American Journal of Hematology
· Гематология
· 2026-10-21
-
Utilization and Outcomes of Hemodialysis and Peritoneal Dialysis in Sickle Cell–Attributed End‐Stage Kidney Disease
Miriam A. Osei,
Mahyar Heydarpour,
J. Kevin Tucker,
Maureen Okam Achebe
American Journal of Hematology
· Гематология
· 2026-10-19
-
Rusfertide for Polycythemia Vera: Incremental Benefit Assessment
Ayalew Tefferi,
Naseema Gangat,
Paola Guglielmelli,
Alessandro M. Vannucchi,
Tiziano Barbui
American Journal of Hematology
· Гематология
· 2026-10-17
-
A Novel Molecular Etiology of Paradoxical Hereditary Thrombocytosis Caused by Germline JAK2 Loss‐of‐Function
Guillaume Beziat,
Elodie Rosa,
Caroline Marty,
Alyx Faurel,
Hana Raslova,
Lucie Rigolot,
Christophe Marzac,
Christine Bellanné‐Chantelot,
William Vainchenker,
Eric Delabesse,
Véronique De Mas,
Isabelle Plo
American Journal of Hematology
· Гематология
· 2026-10-17
-
Clarifying Transfusion Endpoint and Safety Reporting in the Phase III rhTPO Trial
Jia Liu
American Journal of Hematology
· Гематология
· 2026-10-17
-
A Myeloma Masquerade: CCND3‐Rearranged Plasma Cell Myeloma Mimicking Lymphoplasmacytic Lymphoma
Stephen J. Babcock,
Valentina Nardi
American Journal of Hematology
· Гематология
· 2026-10-15
-
Combination Therapy of Vinblastine, Prednisolone, Methotrexate, and 6‐Mercaptopurine as a Front‐Line Therapy for Adult Patients With Langerhans Cell Histiocytosis
Aki Sato,
Nozomi Yusa,
Yukihisa Tanaka,
Miho Ogawa,
Eigo Shimizu,
Koji Jimbo,
Kazuaki Yokoyama,
Masanori Nojima,
Seiya Imoto,
Arinobu Tojo,
Yasuhito Nannya
American Journal of Hematology
· Гематология
· 2026-10-15
-
Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy
Christina I. Shincovich,
Api Chewcharat,
Motohiko Adomi,
Emma E. McGee,
Raphael Kim,
Marta Pirovano,
Jason Prosek,
Srinivas S. Devarakonda,
Joshua Leisring,
Eshetu Obole,
Jasmin Tharakan,
Arti Vaishnav,
Nattawat Klomjit,
Pornlada Likasitwatanakul,
Chester Andrzejewski,
Sajjad Hassan,
Annie Elizabeth Abraham,
Lynne O'Hearn,
Oscar Garcia Valencia,
Jennifer S. McDonald,
M. Salman Sheikh,
Boyoung Michelle Kim,
Priscilla Koirala,
A. Bilal Malik,
Anip Bansal,
Blaithin A. McMah
American Journal of Hematology
· Гематология
· 2026-10-13
ABSTRACT Multiple myeloma light chain cast nephropathy (LCCN) is often treated with plasma exchange (PLEX) or the anti‐CD38 monoclonal antibody, daratumumab. However, rigorous studies supporting these therapies for LCCN are limited....
-
Oral Azacitidine Maintenance After CPX‐351 in Transplant‐Ineligible Patients With Therapy‐Related or Myelodysplasia‐Related Acute Myeloid Leukemia
Caroline Fileni,
Edmond Chiche,
David Swoboda,
Alexander Coltoff,
Rami Komrokji,
Geoffrey Uy,
Sarah Bertoli,
Lenaig Le Clech,
Mael Heiblig,
Ludovic Gabellier,
Patrick Lawrence,
Lydia Kretschmer,
Christoph Röllig,
A. H. Wei,
Fabio Guolo,
Roberto Massimo Lemoli,
Jeffrey Lancet,
David Sallman,
Thomas Cluzeau
American Journal of Hematology
· Гематология
· 2026-10-09
-
A Pooled CRISPR Screen Reveals Genes Critical for Erythroblast Enucleation
Marilou Tetard,
Tianjian Lin,
Nana A. Peterson,
Rebekah C. Gullberg,
Yann Le Guen,
Jasmine Moshiri,
John G. Doench,
Elizabeth S. Egan
American Journal of Hematology
· Гематология
· 2026-10-07
ABSTRACT Terminal erythroid differentiation involves dramatic cellular remodeling that culminates in the expulsion of the nucleus, a process known as enucleation. While enucleation is conserved across mammals and is crucial for the...
-
Pulmonary Alveolar Proteinosis After Allogeneic Stem Cell Transplant in a Patient Undergoing Multiagent Chronic Graft‐Versus‐Host‐Disease Treatment Including Axatilimab
Cydney Nichols,
Noelle Frey,
Saar Gill,
Elizabeth Hexner,
Rebecca L. Hirsh,
Nasheed M. Hossain,
Alison Loren,
Mary Ellen Martin,
Shannon R. McCurdy,
Pashna Munshi,
Linda Perry,
Jacqueline Smith,
Leslie Litzky,
Sujani Madabhushi,
Emily Baumrin,
Vivek N. Ahya,
David L. Porter
American Journal of Hematology
· Гематология
· 2026-10-04
-
Chromosomal Abnormalities, Drug Sensitivity and Resistance in Hematological Malignancies: A Comprehensive Overview by the Francophone Group of Hematological Cytogenetics (GFCH)
Florence Nguyen‐Khac,
Audrey Bidet,
Elise Chapiro,
Nathalie Douet‐Guilbert,
Jean‐Baptiste Gaillard,
Nada Assaf,
Nathalie Auger,
Hend Chaker,
Jasmine Chauzeix,
Inge Govaerts,
Hippolyte Guérineau,
Christine Lefebvre,
Pauline Roynard,
Hélène Guermouche,
Lucienne Michaux,
Marie‐Bérengère Troadec,
Lauren Véronèse
American Journal of Hematology
· Гематология
· 2026-10-04
ABSTRACT Chromosomal abnormalities have a major clinical impact on hematological malignancies, particularly with regard to treatment strategies. To preserve and consolidate fundamental knowledge in this rapidly evolving field, the...
-
Exploring the Patient Perspective of Gene Therapy for Sickle Cell Disease
Clare Nimura,
Lisbel Gonzalez,
Sharl Azar,
Alexander Boucher,
Seethal A. Jacob,
Kristine Karkoska,
Layla Van Doren,
Maayan Leroy‐Melamed,
Patrick T. McGann
American Journal of Hematology
· Гематология
· 2026-10-03
-
Schistocytes Are a Clue, Not a Gatekeeper in Thrombotic Microangiopathy
Akiyoshi Takami,
Shingo Sugawara
American Journal of Hematology
· Гематология
· 2026-10-02
-
Proteomic Profiling of Nodal T‐Follicular Helper Cell Lymphoma Reveals Distinct Biological Signatures and Improves Prognostic Stratification Beyond the IPI
David Beauvais,
Yanis Zirem,
Tristan Cardon,
Soulaimane Aboulouard,
Romain Dubois,
Isabelle Fournier,
Franck Morschhauser,
Michel Salzet,
Ibrahim Yakoub‐Agha,
Marie Duhamel
American Journal of Hematology
· Гематология
· 2026-10-01
ABSTRACT Nodal T‐follicular helper cell lymphoma (nTFHL), most commonly of angioimmunoblastic type, exhibits heterogeneous clinical outcomes that are not fully explained by current clinical and biological variables. While genetic...